chr4-5575608-G-A

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_147127.5(EVC2):​c.3272+632C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.471 in 152,078 control chromosomes in the GnomAD database, including 18,657 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.47 ( 18657 hom., cov: 33)

Consequence

EVC2
NM_147127.5 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.710

Publications

0 publications found
Variant links:
Genes affected
EVC2 (HGNC:19747): (EvC ciliary complex subunit 2) This gene encodes a protein that functions in bone formation and skeletal development. Mutations in this gene, as well as in a neighboring gene that lies in a head-to-head configuration, cause Ellis-van Creveld syndrome, an autosomal recessive skeletal dysplasia that is also known as chondroectodermal dysplasia. Mutations in this gene also cause acrofacial dysostosis Weyers type, also referred to as Curry-Hall syndrome, a disease that combines limb and facial abnormalities. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2009]
EVC2 Gene-Disease associations (from GenCC):
  • acrofacial dysostosis, Weyers type
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet, G2P
  • Ellis-van Creveld syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Myriad Women's Health, Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_147127.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.97).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.837 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_147127.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EVC2
NM_147127.5
MANE Select
c.3272+632C>T
intron
N/ANP_667338.3
EVC2
NM_001166136.2
c.3032+632C>T
intron
N/ANP_001159608.1Q86UK5-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EVC2
ENST00000344408.10
TSL:1 MANE Select
c.3272+632C>T
intron
N/AENSP00000342144.5Q86UK5-1
EVC2
ENST00000310917.6
TSL:1
c.3032+632C>T
intron
N/AENSP00000311683.2Q86UK5-2
EVC2
ENST00000475313.5
TSL:1
n.3032+632C>T
intron
N/AENSP00000431981.1A0A0C4DGE7

Frequencies

GnomAD3 genomes
AF:
0.470
AC:
71471
AN:
151958
Hom.:
18592
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.663
Gnomad AMI
AF:
0.265
Gnomad AMR
AF:
0.447
Gnomad ASJ
AF:
0.346
Gnomad EAS
AF:
0.858
Gnomad SAS
AF:
0.543
Gnomad FIN
AF:
0.430
Gnomad MID
AF:
0.386
Gnomad NFE
AF:
0.340
Gnomad OTH
AF:
0.447
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.471
AC:
71595
AN:
152078
Hom.:
18657
Cov.:
33
AF XY:
0.480
AC XY:
35681
AN XY:
74334
show subpopulations
African (AFR)
AF:
0.664
AC:
27536
AN:
41464
American (AMR)
AF:
0.447
AC:
6831
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.346
AC:
1203
AN:
3472
East Asian (EAS)
AF:
0.858
AC:
4441
AN:
5174
South Asian (SAS)
AF:
0.542
AC:
2618
AN:
4826
European-Finnish (FIN)
AF:
0.430
AC:
4543
AN:
10558
Middle Eastern (MID)
AF:
0.401
AC:
118
AN:
294
European-Non Finnish (NFE)
AF:
0.340
AC:
23106
AN:
67976
Other (OTH)
AF:
0.454
AC:
957
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1789
3579
5368
7158
8947
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
644
1288
1932
2576
3220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.456
Hom.:
5431
Bravo
AF:
0.483
Asia WGS
AF:
0.723
AC:
2512
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.97
CADD
Benign
0.29
DANN
Benign
0.75
PhyloP100
-0.71
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs4689261;
hg19: chr4-5577335;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.